199 related articles for article (PubMed ID: 16672689)
1. Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism.
Sheehan JP; Walke EN
Blood; 2006 May; 107(10):3876-82. PubMed ID: 16672689
[TBL] [Abstract][Full Text] [Related]
2. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
Yuan QP; Walke EN; Sheehan JP
Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
[TBL] [Abstract][Full Text] [Related]
3. Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite.
Buyue Y; Sheehan JP
Blood; 2009 Oct; 114(14):3092-100. PubMed ID: 19414859
[TBL] [Abstract][Full Text] [Related]
4. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
Sheehan JP; Kobbervig CE; Kirkpatrick HM
Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
[TBL] [Abstract][Full Text] [Related]
5. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
[TBL] [Abstract][Full Text] [Related]
6. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.
Misenheimer TM; Buyue Y; Sheehan JP
Biochemistry; 2007 Jul; 46(26):7886-95. PubMed ID: 17563121
[TBL] [Abstract][Full Text] [Related]
7. Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex by an allosteric mechanism.
Sheehan JP; Phan TM
Biochemistry; 2001 Apr; 40(16):4980-9. PubMed ID: 11305914
[TBL] [Abstract][Full Text] [Related]
8. The regulation of factor IXa by supersulfated low molecular weight heparin.
Misenheimer TM; Sheehan JP
Biochemistry; 2010 Nov; 49(46):9997-10005. PubMed ID: 20945941
[TBL] [Abstract][Full Text] [Related]
9. Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase.
Anderson JA; Fredenburgh JC; Stafford AR; Guo YS; Hirsh J; Ghazarossian V; Weitz JI
J Biol Chem; 2001 Mar; 276(13):9755-61. PubMed ID: 11134031
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.
Panteleev MA; Saenko EL; Ananyeva NM; Ataullakhanov FI
Biochem J; 2004 Aug; 381(Pt 3):779-94. PubMed ID: 15104540
[TBL] [Abstract][Full Text] [Related]
11. Nonasaccharide Inhibits Intrinsic Factor Xase Complex by Binding to Factor IXa and Disrupting Factor IXa-Factor VIIIa Interactions.
Xiao C; Zhao L; Gao N; Wu M; Zhao J
Thromb Haemost; 2019 May; 119(5):705-715. PubMed ID: 30900221
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin III-independent effect of depolymerized holothurian glycosaminoglycan (DHG) on acute thromboembolism in mice.
Nagase H; Kitazato KT; Sasaki E; Hattori M; Kitazato K; Saito H
Thromb Haemost; 1997 Feb; 77(2):399-402. PubMed ID: 9157603
[TBL] [Abstract][Full Text] [Related]
13. The Gla domain of factor IXa binds to factor VIIIa in the tenase complex.
Blostein MD; Furie BC; Rajotte I; Furie B
J Biol Chem; 2003 Aug; 278(33):31297-302. PubMed ID: 12782629
[TBL] [Abstract][Full Text] [Related]
14. Effects of Native Fucosylated Glycosaminoglycan, Its Depolymerized Derivatives on Intrinsic Factor Xase, Coagulation, Thrombosis, and Hemorrhagic Risk.
Zhou L; Gao N; Sun H; Xiao C; Yang L; Lin L; Yin R; Li Z; Zhang H; Ji X; Zhao J
Thromb Haemost; 2020 Apr; 120(4):607-619. PubMed ID: 32289860
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
Buyue Y; Misenheimer TM; Sheehan JP
J Thromb Haemost; 2012 Oct; 10(10):2086-98. PubMed ID: 22905983
[TBL] [Abstract][Full Text] [Related]
16. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator.
Barrow RT; Parker ET; Krishnaswamy S; Lollar P
J Biol Chem; 1994 Oct; 269(43):26796-800. PubMed ID: 7929416
[TBL] [Abstract][Full Text] [Related]
18. Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa.
Larson PJ; Stanfield-Oakley SA; VanDusen WJ; Kasper CK; Smith KJ; Monroe DM; High KA
J Biol Chem; 1996 Feb; 271(7):3869-76. PubMed ID: 8632006
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic and anticoagulant activity of depolymerized fragment of the glycosaminoglycan extracted from Stichopus japonicus Selenka.
Suzuki N; Kitazato K; Takamatsu J; Saito H
Thromb Haemost; 1991 Apr; 65(4):369-73. PubMed ID: 1647552
[TBL] [Abstract][Full Text] [Related]
20. Surface loop 199-204 in blood coagulation factor IX is a cofactor-dependent site involved in macromolecular substrate interaction.
Kolkman JA; Christophe OD; Lenting PJ; Mertens K
J Biol Chem; 1999 Oct; 274(41):29087-93. PubMed ID: 10506162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
